Skip to main content

Diabetes with LDL-C greater than 100 – Use of a Lipid Lowering Agent

CBE ID
0618
Endorsement Status
1.1 New or Maintenance
Previous Endorsement Cycle
Is Under Review
No
1.3 Measure Description

The percentage of patients with a diagnosis of diabetes mellitus aged 41 to 75 years, or aged 18 to 40 years with additional risk factors, whose most recent LDL-C value is more than 100 mg/dL and who are taking a lipid lowering agent.

        • 1.14 Numerator

          Patients who are taking a lipid lowering agent

        • 1.15 Denominator

          Patients with a diagnosis of diabetes mellitus aged 41 to 75 years, or aged 18 to 40 years with additional risk factors, whose most recent LDL-C value is more than 100 mg/dL.

        • Exclusions

          SPECIFIC DENOMINATOR EXCLUSIONS

          One of the following is correct:
          1. Presence of patient data c via online PHR or telephonic nurse assessment confirming breast feeding in the past 6 months
          2. If Pregnancy Loose Version Validation is confirmed for the member (see below)

          General exclusions:
          1. Evidence of metastatic disease or active treatment of malignancy (chemotherapy or radiation therapy) in the last 6 months;
          2. Patients who have been in a skilled nursing facility in the last 3 months
          3. Patients who are terminally ill or in Hospice
          4. Patient or provider feedback indicating allergy, intolerance or other contraindication to lipid lowering therapy anytime in the past

        • Most Recent Endorsement Activity
          Measure Retired and Endorsement Removed National Voluntary Consensus Standards For Clinically Enriched Administrative Data
          Initial Endorsement
          Last Updated
          Removal Date
        • Steward
          ActiveHealth Management
          Steward Organization POC Email